Language: BG BG
← Back to results
Recruiting NCT02848274

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Conditions: Mycosis Fungoides Non-Hodgkin's Lymphoma

Sponsor: Stanford University

trial.available_in: БГ
Overview
The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.
Who can participate
Inclusion Criteria * Diagnosis of advanced stage MF or SS (Stages IIB - IVB) within 6 months of presentation to the participating center * Patients that are expected to have care administered at the participating center or jointly with referring physician(s) where follow-up data would be available Exclusion Criteria * Patients diagnosed with early stage MF/SS (Stages IA-IIA) before progressing to advanced stage * Patients diagnosed with advanced MF/SS more than 6 months prior to initial presentation to the participating center * Exclude one-time consultation type of new patients.
Locations 7
Argentina (1)
Hospital Italiano de Buenos Aires
Buenos Aires
Australia (1)
Peter MacCallum Cancer Center,
Melbourne
Brazil (1)
University of Sao Paulo Medical School
São Paulo
Jose Sanches, MD
China (1)
Peking University First Hospital
Beijing
Japan (1)
The University of Tokyo
Tokyo
Tomomitsu Miyagaki
United Kingdom (1)
University Hospitals Birmingham
Birmingham
United States (1)
City of Hope
Duarte , California
Christiane Querfeld
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Healthy volunteers
No
Start date
01.10.2016
Completion date
01.03.2027
Registry ID
NCT02848274
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.